Changwoo Park
Research Subjects
Changwoo Park has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Chang-Seop Lee
Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital
1 shared publication - Daeui Park
Center for National Toxicology AI and Data, Korea Institute of Toxicology, Republic of Korea
1 shared publication - Dongju Park
Biometrology Group, Korea Research Institute of Standards and Science (KRISS), Daejeon 34113, Republic of Korea
1 shared publication - Edmond Changkyun Park
Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Cheongju, Republic of Korea
1 shared publication Eunsang Yoon
Qualidade e confiabilidade dos trabalhos que publica, conduz
1 shared publication- Gun-Soo Park
Korea Food Research Institute
1 shared publication
Latest Publications
- Open Access
- 31 July 2023
- Published by Editora Artemis
- p. 193-205
A STUDY ON THE PROGRAM MANAGEMENT DIRECTION OF MEGAPROJECT FOR SAEMANGEUM DELVELOPMENT IN KOREA
- 31 July 2023
- Published by Editora Artemis
- p. 193-205
Open AccessA STUDY ON THE PROGRAM MANAGEMENT DIRECTION OF MEGAPROJECT FOR SAEMANGEUM DELVELOPMENT IN KOREA
- Open Access
Robust and sensitive detection of SARS-CoV-2 using PCR based methods
The World Health Organization (WHO) has declared the Coronavirus disease 2019 (COVID-19) as an international health emergency. Current diagnostic tests are based on the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method, the gold standard test that involves the amplification of viral RNA. However, the RT-qPCR assay has limitations in terms of sensitivity and quantification. In this study, we tested both qPCR and droplet digital PCR (ddPCR) to detect low amounts of viral RNA. The cycle threshold (CT) of viral RNA by RT-PCR significantly varied according to the sequence of primer and probe sets with in vitro transcript (IVT) RNA or viral RNA as templates, whereas the copy number of viral RNA by ddPCR was effectively quantified with IVT RNA, cultured viral RNA, and RNA from clinical samples. Furthermore, the clinical samples were assayed via both methods, and the sensitivity of the ddPCR was determined to be significantly higher than RT-qPCR. These findings suggest that ddPCR could be used as a highly sensitive and compatible diagnostic method for viral RNA detection.
Open AccessRobust and sensitive detection of SARS-CoV-2 using PCR based methods
The World Health Organization (WHO) has declared the Coronavirus disease 2019 (COVID-19) as an international health emergency. Current diagnostic tests are based on the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method, the gold standard test that involves the amplification of viral RNA. However, the RT-qPCR assay has limitations in terms of sensitivity and quantification. In this study, we tested both qPCR and droplet digital PCR (ddPCR) to detect low amounts of viral RNA. The cycle threshold (CT) of viral RNA by RT-PCR significantly varied according to the sequence of primer and probe sets with in vitro transcript (IVT) RNA or viral RNA as templates, whereas the copy number of viral RNA by ddPCR was effectively quantified with IVT RNA, cultured viral RNA, and RNA from clinical samples. Furthermore, the clinical samples were assayed via both methods, and the sensitivity of the ddPCR was determined to be significantly higher than RT-qPCR. These findings suggest that ddPCR could be used as a highly sensitive and compatible diagnostic method for viral RNA detection.